Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Joly

Showing results (101-110 of 346) with videos related to

Pageof 35
Sort By:
Frontiers in Pharmacology|November 6, 2023
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's databaseRachel Prevost, Basile Chretien, Elise-Marie Minoc, et al.
European Urology|September 2, 2020
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological ResponsesChristian Pfister, Gwenaelle Gravis, Aude Fléchon, et al.
The European Journal of Neuroscience|January 3, 2022
Self-referential processes and resting-state connectivity in breast cancer patients before and 1 year after chemotherapyJoy Perrier, Gina Joue, Béatrice Desgranges, et al.
Histology and Histopathology|February 19, 2009
Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinomaAlexandre Labiche, Nicolas Elie, Paulette Herlin, et al.
Gynecologic Oncology|January 3, 2013
Quality of life in long-term cervical cancer survivors: a population-based studyGwenael Le Borgne, Mariette Mercier, Anne-Sophie Woronoff, et al.
Plos One|December 2, 2014
Evaluation of the impact of the cancer therapy everolimus on the central nervous system in miceMartine Dubois, Vadim Le Joncour, Marie-Christine Tonon, et al.
Clinical Genitourinary Cancer|August 21, 2009
Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A GETUG phase II studyFlorence Joly, Nadine Houédé, Sabine Noal, et al.
Frontiers in Psychology|October 3, 2022
Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in FranceFeriel Yahi, Justine Lequesne, Olivier Rigal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunityBenjamin Terrier, Florence Joly, Thomas Vazquez, et al.
BMC Genomics|December 8, 2007
Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant miceNicolas F Delahaye, Nicolas Coltel, Denis Puthier, et al.
Pageof 35

Showing results (101-110 of 346) with videos related to

Sort By:
Pageof 35
Frontiers in Pharmacology|November 6, 2023
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's databaseRachel Prevost, Basile Chretien, Elise-Marie Minoc, et al.
European Urology|September 2, 2020
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological ResponsesChristian Pfister, Gwenaelle Gravis, Aude Fléchon, et al.
The European Journal of Neuroscience|January 3, 2022
Self-referential processes and resting-state connectivity in breast cancer patients before and 1 year after chemotherapyJoy Perrier, Gina Joue, Béatrice Desgranges, et al.
Histology and Histopathology|February 19, 2009
Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinomaAlexandre Labiche, Nicolas Elie, Paulette Herlin, et al.
Gynecologic Oncology|January 3, 2013
Quality of life in long-term cervical cancer survivors: a population-based studyGwenael Le Borgne, Mariette Mercier, Anne-Sophie Woronoff, et al.
Plos One|December 2, 2014
Evaluation of the impact of the cancer therapy everolimus on the central nervous system in miceMartine Dubois, Vadim Le Joncour, Marie-Christine Tonon, et al.
Clinical Genitourinary Cancer|August 21, 2009
Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A GETUG phase II studyFlorence Joly, Nadine Houédé, Sabine Noal, et al.
Frontiers in Psychology|October 3, 2022
Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in FranceFeriel Yahi, Justine Lequesne, Olivier Rigal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunityBenjamin Terrier, Florence Joly, Thomas Vazquez, et al.
BMC Genomics|December 8, 2007
Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant miceNicolas F Delahaye, Nicolas Coltel, Denis Puthier, et al.
Pageof 35